Incidence of Antiresorptive Agent-Related Osteonecrosis of the Jaw in Urologic Cancers
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is a serious adverse event of bone resorption inhibitors (BRIs), such as zoledronic acid and denosumab. Based on the results of phase 3 clinical trials for BRIs, the frequency of ARONJ is 1 to 2%, but the actual frequency is presumed to b...
Description complète
Détails bibliographiques
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 68(2022), 1 vom: 02. Jan., Seite 1-6
|
|---|
| Auteur principal: |
Kawanishi, Hiroaki
(Auteur) |
|---|
| Autres auteurs: |
Yokozeki, Hitoshi,
Hoshiyama, Akihiro,
Watanabe, Hiroki,
Funahashi, Yurina,
Fujiwara, Maki,
Takashima, Yasushi,
Shintani, Motoko,
Yui, Shumpei,
Okumura, Kazuhiro |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | Japanese |
|---|
| Publié: |
2022
|
|---|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Sujets: | Journal Article
Bone Density Conservation Agents |
|---|